FDA Adverse Event
Injury
Summary report: N
UNKNOWN ENDO GIA SULU
MDR report key: 11979728
·
Received June 10, 2021
Report
- Report Number
- 1219930-2021-02305
- Event Type
- Injury
- Date Received
- June 10, 2021
- Date of Event
- July 19, 2020
- Report Date
- June 10, 2021
- Manufacturer
- COVIDIEN LP LLC NORTH HAVEN
- Product Code
- GDW
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- PA, US
- Reporter Occupation
- PHYSICIAN
Narratives
Additional Manufacturer Narrative · 1
TITLE: MARGIN-POSITIVE PANCREATIC DUCTAL ADENOCARCINOMA DURING PANCREATICODUODENECTOMY: ADDITIONAL RESECTION DOES NOT IMPROVE SURVIVAL SOURCE: ANN SURGONCOL (2021) 28:1552¿1562 HTTPS://DOI.ORG/10.1245/S10434-020-09000-9. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
Description of Event or Problem · 1
ACCORDING TO LITERATURE SOURCE OF STUDY PERFORMED 2006 AND 2015, A STUDY ANALYZED OUTCOMES OF PATIENTS WHO UNDERWENT PANCREATICODUODENECTOMY FOR PANCREATIC DUCTAL ADENOCARCINOMA. THE STAPLER WAS USED TO DIVIDE THE DUODENUM. THERE WERE 501 PATIENTS IN THE STUDY AND COMPLICATIONS INCLUDED: POSTOPERATIVE HEMORRHAGE, PANCREATIC FISTULA. READMISSIONS WERE REPORTED BUT NO OTHER INTERVENTIONS WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 872056 | UNKNOWN ENDO GIA SULU | STAPLE, IMPLANTABLE | GDW | COVIDIEN LP LLC NORTH HAVEN | UNKNOWN ENDO GIA SULU |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 68 YR | Hospitalization| O |